Afuco™ Anti-Human ESR1 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-ESR1 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is an antibody binds to ER-α36, ER-α36 positively regulates HER2 expression and the population of ALDH1 positive breast cancer cells, and suggested that non-genomic estrogen signaling mediated by ER-α36 is involved in maintenance and regulation of breast cancer stem cells.
Supplier Creative Biolabs
Product # AFC-236CL
Pricing Inquiry
Host Human
Target ESR1
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at -20°C. Open under aseptic conditions.
Feedback